Literature DB >> 17465480

Contribution of mononuclear bone marrow cells to carbon tetrachloride-induced liver fibrosis in rats.

Bao-Qiang Cao1, Ji-Zong Lin, Yue-Si Zhong, Shao-Bin Huang, Nan Lin, Zhao-Feng Tang, Rui Chen, Peng Xiang, Rui-Yun Xu.   

Abstract

AIM: To study the inhibitory effect of mononuclear bone marrow cell (BMC) transplantation on carbon tetrachloride (CCl(4)) -induced liver fibrosis in rats.
METHODS: Rat liver fibrosis models were induced by CCl(4) and alcohol administration. After 8 wk, twenty rats were randomly allocated into treatment group (n = 10) and control group (n = 10). BMC were infused into the rats in treatment group via the portal vein, while heparinized saline was infused in control group. CCl(4) was hypodermically injected into the rats twice a week for 4 wk. At the end of wk 12, all rats were humanely sacrificed. Liver samples were taken and stained with HE or Masson trichrome. The general conditions, liver fibrosis (hydroxyproline and collagen fibre) and liver pathological grades in rats were evaluated.
RESULTS: The general conditions of the rats in treatment group improved markedly, but not in control group. Hydroxyproline was 504.6 +/- 128.8 microg/g in treatment group, and 596.0 +/- 341.8 microg/g in control group. The percentage of collagen fibre was 3.75% +/- 0.98% in treatment group and 5.02% +/- 0.44% in control group. There was a significant difference between the two groups (P < 0.05). Liver pathological grade decreased from grade IV to grade III partially in treatment group (P < 0.05) with no obvious improvement in control group (P > 0.05). There was a significant difference between treatment group and control group (P < 0.05).
CONCLUSION: Transplantation of BMC can improve liver fibrosis due to chronic liver injury in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17465480      PMCID: PMC4149966          DOI: 10.3748/wjg.v13.i12.1851

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.

Authors:  K L Rudolph; S Chang; M Millard; N Schreiber-Agus; R A DePinho
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

2.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo.

Authors:  E Lagasse; H Connors; M Al-Dhalimy; M Reitsma; M Dohse; L Osborne; X Wang; M Finegold; I L Weissman; M Grompe
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

3.  Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell.

Authors:  D S Krause; N D Theise; M I Collector; O Henegariu; S Hwang; R Gardner; S Neutzel; S J Sharkis
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

4.  A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver.

Authors:  Naoki Yamamoto; Shuji Terai; Shinya Ohata; Tomomi Watanabe; Kaoru Omori; Koh Shinoda; Koji Miyamoto; Toshiaki Katada; Isao Sakaida; Hiroshi Nishina; Kiwamu Okita
Journal:  Biochem Biophys Res Commun       Date:  2004-01-23       Impact factor: 3.575

Review 5.  Bone marrow-derived stem cells and "plasticity".

Authors:  A Hüttmann; C L Li; U Dührsen
Journal:  Ann Hematol       Date:  2003-07-24       Impact factor: 3.673

6.  Stem cells and liver disease: promise laced with confusion and intrigue.

Authors:  Nick A Shackel; Don C Rockey
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

7.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.

Authors:  J P Iredale; R C Benyon; J Pickering; M McCullen; M Northrop; S Pawley; C Hovell; M J Arthur
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

8.  Regeneration of hepatocyte 'buds' in cirrhosis from intrabiliary stem cells.

Authors:  Olga Falkowski; Hee Jung An; I Andreea Ianus; Luis Chiriboga; Herman Yee; A Brian West; Neil D Theise
Journal:  J Hepatol       Date:  2003-09       Impact factor: 25.083

9.  Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

Authors:  Stefanie U Wiemann; Ande Satyanarayana; Martina Tsahuridu; Hans L Tillmann; Lars Zender; Juergen Klempnauer; Peer Flemming; Sonia Franco; Maria A Blasco; Michael P Manns; K Lenhard Rudolph
Journal:  FASEB J       Date:  2002-07       Impact factor: 5.191

10.  Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract.

Authors:  Ryuichi Okamoto; Tomoharu Yajima; Motomi Yamazaki; Takanori Kanai; Makio Mukai; Shinichiro Okamoto; Yasuo Ikeda; Toshifumi Hibi; Johji Inazawa; Mamoru Watanabe
Journal:  Nat Med       Date:  2002-08-26       Impact factor: 53.440

View more
  4 in total

Review 1.  Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.

Authors:  Mukaddes Esrefoglu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

2.  Bone marrow progenitor cells do not contribute to liver fibrogenic cells.

Authors:  Bruno Diaz Paredes; Lanuza Alaby Pinheiro Faccioli; Luiz Fernando Quintanilha; Karina Dutra Asensi; Camila Zaverucha do Valle; Paulo César Canary; Christina Maeda Takiya; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  World J Hepatol       Date:  2012-10-27

3.  Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model.

Authors:  Abbas Piryaei; Mojtaba Rezazadeh Valojerdi; Mansoureh Shahsavani; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

4.  Decreased collagen types I and IV, laminin, CK-19 and α-SMA expression after bone marrow cell transplantation in rats with liver fibrosis.

Authors:  S N Carvalho; D C Lira; G P Oliveira; A A Thole; A C Stumbo; C E Caetano; R G Marques; L Carvalho
Journal:  Histochem Cell Biol       Date:  2010-10-21       Impact factor: 4.304

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.